Development of a novel trivalent invasive non-typhoidal Salmonella outer membrane vesicles based vaccine against salmonellosis and fowl typhoid in chickens - PubMed (original) (raw)
. 2022 Mar;227(2):152183.
doi: 10.1016/j.imbio.2022.152183. Epub 2022 Jan 31.
Affiliations
- PMID: 35121180
- DOI: 10.1016/j.imbio.2022.152183
Development of a novel trivalent invasive non-typhoidal Salmonella outer membrane vesicles based vaccine against salmonellosis and fowl typhoid in chickens
Suhrid Maiti et al. Immunobiology. 2022 Mar.
Abstract
Poultry animals act as natural reservoirs of invasive non-typhoidal Salmonella [iNTS] serovars and consumption of iNTS contaminated poultry meat and eggs is one of the major sources of iNTS infection in developed and developing countries. Irrational use of antibiotics in the poultry industry gives rise to the global emergence of multi drug resistant iNTS strains. Among different strategies to control iNTS infection in poultry farms, vaccination is now being widely used. There are several licensed vaccines available in the market for poultry animals to ameliorate iNTS infection but none of them have broad spectrum protective efficacy. In this study we have formulated a single novel trivalent iNTS outer membrane vesicles [OMVs] based immunogen which can confer long term broad spectrum protection against most prevalent iNTS serovars. We have isolated OMVs from Salmonella Typhimurium [ST], Salmonella Enteritidis [SE], and Salmonella Gallinarum [SG] and formulated the trivalent immunogen by mixing OMVs in a 1:1:1 ratio. One day old chicks were immunized thrice via oral route at two week intervals. Vaccination significantly induced serovar specific antibodies detected up to 180 days post immunization. Post challenge with both homologous and heterologous [S. Infantis] serovars, immunized birds showed reduced level of fecal shedding and organ invasion. A long term efficacy study also showed reduced levels of tissue invasion up to one year post immunization. These results demonstrate that our novel formulation of immunogen could be a broad spectrum potential vaccine for both layer and broiler breeds against iNTS mediated salmonellosis and fowl typhoid.
Keywords: Chicken model; Efficacy study; Outer membrane vesicles; Salmonella Enteritidis; Salmonella Gallinarum; Salmonella Typhimurium; Trivalent vaccine.
Copyright © 2022 Elsevier GmbH. All rights reserved.
Similar articles
- Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model.
Maiti S, Howlader DR, Halder P, Bhaumik U, Dutta M, Dutta S, Koley H. Maiti S, et al. Vaccine. 2021 Jan 8;39(2):380-393. doi: 10.1016/j.vaccine.2020.11.040. Epub 2020 Dec 7. Vaccine. 2021. PMID: 33303233 - Trivalent outer membrane vesicles-based combination vaccine candidate induces protective immunity against Campylobacter and invasive non-typhoidal Salmonella in adult mice.
Banerjee S, Halder P, Das S, Maiti S, Withey JH, Mitobe J, Chowdhury G, Kitahara K, Miyoshi SI, Mukhopadhyay AK, Dutta S, Koley H. Banerjee S, et al. Med Microbiol Immunol. 2024 Oct 15;213(1):21. doi: 10.1007/s00430-024-00805-z. Med Microbiol Immunol. 2024. PMID: 39407046 - rOmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms.
Li Q, Ren J, Xian H, Yin C, Yuan Y, Li Y, Ji R, Chu C, Qiao Z, Jiao X. Li Q, et al. Vaccine. 2020 Oct 21;38(45):7094-7099. doi: 10.1016/j.vaccine.2020.08.074. Epub 2020 Sep 18. Vaccine. 2020. PMID: 32951940 - The global burden and epidemiology of invasive non-typhoidal Salmonella infections.
Balasubramanian R, Im J, Lee JS, Jeon HJ, Mogeni OD, Kim JH, Rakotozandrindrainy R, Baker S, Marks F. Balasubramanian R, et al. Hum Vaccin Immunother. 2019;15(6):1421-1426. doi: 10.1080/21645515.2018.1504717. Epub 2018 Sep 5. Hum Vaccin Immunother. 2019. PMID: 30081708 Free PMC article. Review. - Decoding the invasive nature of a tropical pathogen of concern: The invasive non-Typhoidal Salmonella strains causing host-restricted extraintestinal infections worldwide.
Hajra D, Nair AV, Chakravortty D. Hajra D, et al. Microbiol Res. 2023 Dec;277:127488. doi: 10.1016/j.micres.2023.127488. Epub 2023 Sep 12. Microbiol Res. 2023. PMID: 37716125 Review.
Cited by
- Holistic Strategies to Control Salmonella Infantis: An Emerging Challenge in the European Broiler Sector.
Montoro-Dasi L, Lorenzo-Rebenaque L, Marco-Fuertes A, Vega S, Marin C. Montoro-Dasi L, et al. Microorganisms. 2023 Jul 6;11(7):1765. doi: 10.3390/microorganisms11071765. Microorganisms. 2023. PMID: 37512937 Free PMC article. Review. - Lacticaseibacillus rhamnosus alleviates intestinal inflammation and promotes microbiota-mediated protection against Salmonella fatal infections.
Peng X, Ed-Dra A, Song Y, Elbediwi M, Nambiar RB, Zhou X, Yue M. Peng X, et al. Front Immunol. 2022 Aug 11;13:973224. doi: 10.3389/fimmu.2022.973224. eCollection 2022. Front Immunol. 2022. PMID: 36032095 Free PMC article. - The Evolution of Vaccines Development across Salmonella Serovars among Animal Hosts: A Systematic Review.
Siddique A, Wang Z, Zhou H, Huang L, Jia C, Wang B, Ed-Dra A, Teng L, Li Y, Yue M. Siddique A, et al. Vaccines (Basel). 2024 Sep 18;12(9):1067. doi: 10.3390/vaccines12091067. Vaccines (Basel). 2024. PMID: 39340097 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources